ZVRA Stock Analysis: Buy, Sell, or Hold?
ZVRA - Zevra Therapeutics, Inc. Common Stock
$13.00
0.35 (2.77%)
▲
5d:
+3.59%
30d:
+23.93%
90d:
+38.0%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ZVRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ZVRA shows positive signals but monitor for confirmation. Market pricing in 2.2% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: ZVRA shows positive signals but monitor for confirmation. Market pricing in 2.2% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.70
Based on 0.9% avg growth
INTRINSIC VALUE TODAY
$7.89
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZVRA is currently trading at $13.00, which is considered extended relative to its 30-day fair value range of $10.43 to $12.49. The stock's valuation (Forward PE: 10.9) is in line with its historical norms (10.2). At these levels, the market is pricing in 2.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ZVRA is in a strong uptrend. Immediate support is located at $12.18, while resistance sits at $14.27.
Market Sentiment: ZVRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.89 (+114.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZVRA is in a strong uptrend. Immediate support is located at $12.18, while resistance sits at $14.27.
Market Sentiment: ZVRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.89 (+114.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.43 -
$12.49
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 114.5% below Wall St target ($27.89)
- NEUTRAL: Market pricing in 2.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$10.43 -
$12.49
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.18
Resistance Level
$14.27
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.88
Wall Street Target
$27.89
(+114.5%)
Revenue Growth (YoY)
77.5%
Profit Margin
101.6%
Valuation Premium vs History
+2.2% premium
PE vs Historical
10.9 vs 10.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$13.29
(+2%)
2-Year Target
$13.58
(+4%)
3-Year Target
$13.88
(+7%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$13.01
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -2.3%)
$24.26
(+87%)
Base:
(SPY PE: 10.9, Growth: -2.3%)
$12.12
(-7%)
Bear:
(PE: 9.2, Growth: -2.3%)
$10.30
(-21%)
📈
Valuation based on Current Earnings
Trailing PE: 6.29 | Current EPS (TTM): $2.01
Bull Case
$8.27
(-36%)
Analyst growth -40.5%, PE expands to 6.9
Base Case
$7.52
(-42%)
Market implied -40.5%, PE stable at 6.3
Bear Case
$8.60
(-34%)
Severe decline -20.0%, PE contracts to 5.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 7:57 PM ET
Data refreshes hourly during market hours. Next update: 8:57 PM
Data refreshes hourly during market hours. Next update: 8:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZVRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua Schafer
SELL
10500 shares
2026-02-03
Timothy J Sangiovanni
SELL
3000 shares
2026-02-03
Neil F Mcfarlane
SELL
91000 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
Advanced ZVRA Option Strategies
Professional options setups generated by AI based on today's ZVRA price and gamma walls.
